Accéder au contenu
Merck

Metabolism of liriodendrin and syringin by human intestinal bacteria and their relation to in vitro cytotoxicity.

Archives of pharmacal research (1999-03-11)
D H Kim, K T Lee, E A Bae, M J Han, H J Park
RÉSUMÉ

When liriodendrin or syringin was incubated for 24 h with human intestinal bacteria, two metabolites, (+)-syringaresinol-beta-D-glucopyranoside and (+)-syringaresinol, from liriodendrin and one metabolite, synapyl alcohol, from syringin were produced. The metabolic time course of liriodendrin was as follows: at early time, liriodendrin was converted to (+)-syringaresinol-beta-D-glucopyranoside, and then (+)-syringaresinol. The in vitro cytotoxicities of these metabolites, (+)-syringaresinol and synapyl alcohol, were superior to those of liriodendrin and syringin.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Supelco
Eleutheroside E, analytical standard